2 employees
VAXDIGM focuses on the development of advanced vaccines and future vaccines.
2021
Vaxdigm raised undisclosed on October 11, 2022
Investors: TIPS Town
Vaxdigm raised undisclosed on May 10, 2022
Investors: New Paradigm Investment Co., Ltd.